Asbestos induces reduction of tumor immunity

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Kumagai Takei, Naoko ^a   Maeda, Megumi ^a,b   Chen, Ying ^a,c   Matsuzaki, Hidenori ^a   Lee, Suni ^a   Nishimura, Yasumitsu ^a   Hiratsuka, Junichi ^a   Otsuki, Takemi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOLITE; AMOSITE; AMPHIBOLE; ANTHOPHYLLITE; ASBESTOS; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR3; CHRYSOTILE; CROCIDOLITE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PROTEIN BCL 2; SERPENTINE; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TREMOLITE; UNCLASSIFIED DRUG; CARCINOGEN; TUMOR ANTIGEN;

APOPTOSIS; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; LUNG CANCER; MESOTHELIOMA; MULTIPLE MYELOMA; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH17 CELL; TUMOR IMMUNITY; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DNA DAMAGE; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LUNG TUMOR; OXIDATIVE STRESS;

ANIMALS; ANTIGENS, NEOPLASM; ASBESTOS; CARCINOGENS; DISEASE MODELS, ANIMAL; DNA DAMAGE; EARLY DETECTION OF CANCER; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY; IMMUNOSUPPRESSION; LUNG NEOPLASMS; MESOTHELIOMA; OXIDATIVE STRESS;

EID: 84855174167     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/481439     Document Type: Review

References (55)

1. Asbestos scandal Nature 2010 468 7326 868
2. Kumagai S., Kurumatani N., Mapping the risk of mesothelioma due to neighborhood asbestos exposure American Journal of Respiratory and Critical Care Medicine 2008 178 6 624 629
3. Kumagai S., Kurumatani N., Asbestos fiber concentration in the area surrounding a former asbestos cement plant and excess mesothelioma deaths in residents American Journal of Industrial Medicine 2009 52 10 790 798
4. Kumagai S., Kurumatani N., Tsuda T., Yorifuji T., Suzuki E., Increased risk of lung cancer mortality among residents near an asbestos product manufacturing plant International Journal of Occupational and Environmental Health 2010 16 3 268 278
5. Yamanaka T., Tanaka F., Hasegawa S., Okada M., Soejima T., Kamikonya N., Fukuoka K., Nakano T., A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma Japanese Journal of Clinical Oncology 2009 39 3 186 188
6. Hasegawa S., Tanaka F., Malignant mesothelioma: current status and perspective in Japan and the world General Thoracic and Cardiovascular Surgery 2008 56 7 317 323 (Pubitemid 351952058)
7. Ohashi R., Tajima K., Takahashi F., Cui R., Gu T., Shimizu K., Nishio K., Fukuoka K., Nakano T., Takahashi K., Osteopontin modulates malignant pleural mesothelioma cell functions in vitro Anticancer Research 2009 29 6 2205 2214
8. Tabata C., Hirayama N., Tabata R., Yasumitsu A., Yamada S., Murakami A., Iida S., Tamura K., Fukuoka K., Kuribayashi K., Terada T., Nakano T., A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma European Respiratory Journal 2010 36 5 1099 1105
9. Yasumitsu A., Tabata C., Tabata R., Hirayama N., Murakami A., Yamada S., Terada T., Iida S., Tamura K., Fukuoka K., Kuribayashi K., Nakano T., Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma Journal of Thoracic Oncology 2010 5 4 479 483
10. Okumura Y., Tanaka F., Yoneda K., Hashimoto M., Takuwa T., Kondo N., Hasegawa S., Circulating tumor cells in pulmonary venous blood of primary lung cancer patients Annals of Thoracic Surgery 2009 87 6 1669 1675
11. Tanaka F., Yoneda K., Kondo N., Hashimoto M., Takuwa T., Matsumoto S., Okumura Y., Rahman S., Tsubota N., Tsujimura T., Kuribayashi K., Fukuoka K., Nakano T., Hasegawa S., Circulating tumor cell as a diagnostic marker in primary lung cancer Clinical Cancer Research 2009 15 22 6980 6986
12. Murakami H., Mizuno T., Taniguchi T., Fujii M., Ishiguro F., Fukui T., Akatsuka S., Horio Y., Hida T., Kondo Y., Toyokuni S., Osada H., Sekido Y., LATS2 is a tumor suppressor gene of malignant mesothelioma Cancer Research 2011 71 3 873 883
13. Sekido Y., Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation Pathology International 2011 61 6 331 344
14. Goto Y., Shinjo K., Kondo Y., Shen L., Toyota M., Suzuki H., Gao W., An B., Fujii M., Murakami H., Osada H., Taniguchi T., Usami N., Kondo M., Hasegawa Y., Shimokata K., Matsuo K., Hida T., Fujimoto N., Kishimoto T., Issa J. P. J., Sekido Y., Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma Cancer Research 2009 69 23 9073 9082
15. Toyokuni S., Mechanisms of asbestos-induced carcinogenesis Nagoya Journal of Medical Science 2009 71 1-2 1 10
16. Toyokuni S., Role of iron in carcinogenesis: cancer as a ferrotoxic disease Cancer Science 2009 100 1 9 16
17. Hu Q., Akatsuka S., Yamashita Y., Ohara H., Nagai H., Okazaki Y., Takahashi T., Toyokuni S., Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma Laboratory Investigation 2010 90 3 360 373
18. Toyokuni S., Iron as a target of chemoprevention for longevity in humans. Free Radical Research. In press
19. Nagai H., Toyokuni S., Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials Archives of Biochemistry and Biophysics 2010 502 1 1 7
20. Craighead J. E., Gibbs A. I., Pooley F., Craighead J. E., Gibbs A. R., Mineralogy of asbestos Asbestos and Its Diseases 2008 New York, NY, USA Oxford University Press 23 38
21. Roggli V. L., Coin P., Roggli V. L., Oury T. D., Sporn T. A., Mineralogy of asbestos Pathology of Asbestos-Associated Diseases 2004 2nd New York, NY, USA Springer Science and Business Media 1 16
22. Uber C. L., McReynolds R. A., Immunotoxicology of silica Critical Reviews in Toxicology 1982 10 4 303 319
23. Steenland K., Goldsmith D. F., Silica exposure and autoimmune diseases American Journal of Industrial Medicine 1995 28 5 603 608
24. Reyes H., Ojo-Amaize E. A., Peter J. B., Silicates, silicones and autoimmunity Israel Journal of Medical Sciences 1997 33 4 239 242 (Pubitemid 27466601)
25. D'Cruz D., Autoimmune diseases associated with drugs, chemicals and environmental factors Toxicology Letters 2000 112-113 421 432 (Pubitemid 30138154)
26. Mayes M. D., Epidemiologic studies of environmental agents and systemic autoimmune diseases Environmental Health Perspectives 1999 107 5 743 748 (Pubitemid 29527779)
27. Schreiber J., Koschel D., Kekow J., Waldburg N., Goette A., Merget R., Rheumatoid pneumoconiosis (Caplan's syndrome) European Journal of Internal Medicine 2010 21 3 168 172
28. Otsuki T., Miura Y., Nishimura Y., Hyodoh F., Takata A., Kusaka M., Katsuyama H., Tomita M., Ueki A., Kishimoto T., Alterations of Fas and Fas-related molecules in patients with silicosis Experimental Biology and Medicine 2006 231 5 522 533
29. Otsuki T., Maeda M., Murakami S., Hayashi H., Miura Y., Kusaka M., Nakano T., Fukuoka K., Kishimoto T., Hyodoh F., Ueki A., Nishimura Y., Immunological effects of silica and asbestos Cellular and Molecular Immunology 2007 4 4 261 268
30. Wu P., Miura Y., Hyodoh F., Nishimura Y., Hatayama T., Hatada S., Sakaguchi H., Kusaka M., Katsuyama H., Tomita M., Otsuki T., Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients International Journal of Immunopathology and Pharmacology 2006 19 2 357 368 (Pubitemid 44181958)
31. Otsuki T., Hayashi H., Nishimura Y., Hyodo F., Maeda M., Kumagai N., Miura Y., Kusaka M., Uragami K., Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients International Journal of Immunopathology and Pharmacology 2011 24 supplement 1 11S 16S
32. Hayashi H., Miura Y., Maeda M., Murakami S., Kumagai N., Nishimura Y., Kusaka M., Urakami K., Fujimoto W., Otsuki T., Reductive alteration of the regulatory function of the CD4 + CD25 + T cell fraction in silicosis patients International Journal of Immunopathology and Pharmacology 2010 23 4 1099 1109
33. Rolston R., Oury D., Roggli V. L., Oury T. D., Sporn T. A., Other neoplasia Pathology of Asbestos-Associated Diseases 2004 2nd New York, NY, USA Springer Science and Business Media 217 230
34. Lemen R. A., Dodson R. F., Hammared S. P., Epidemiology of asbestos-related diseases and the knowledge that led to what is known today Asbestos, Risk Assessment, Epidemiology, and Health Effects 2006 Boca Ratton, Fla, USA CRC Press, Taylor and Francis Group 201 308
35. Craughea J. E., Craighead J. E., Gibbs A. R., Nonthoracic cancers possibly resulting from asbestos exposure Asbestos and Its Diseases 2008 New York, NY, USA Oxford University Press 230 252
36. Barrett J. C., Lamb P. W., Wiseman R. W., Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers Environmental Health Perspectives 1989 81 81 89 (Pubitemid 19156867)
37. Davis J. M., Mineral fibre carcinogenesis: experimental data relating to the importance of fibre type, size, deposition, dissolution and migration IARC Scientific Publications 1989 90 33 45
38. Miyoshi I., Kubonishi I., Yoshimoto S., Shiraishi Y., A T-cell line derived from normal human cord-leukocytes by co-culturing with human leukemic T-cells Gann 1981 72 6 978 981 (Pubitemid 12172471)
39. Miyoshi I., Kubonishi I., Yoshimoto S., Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells Nature 1981 294 5843 770 771 (Pubitemid 12174453)
40. Hyodoh F., Takata-Tomokuni A., Miura Y., Sakaguchi H., Hatayama T., Hatada S., Katsuyama H., Matsuo Y., Otsuki T., Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A Scandinavian Journal of Immunology 2005 61 5 442 448 (Pubitemid 40695015)
41. Liu G., Beri R., Mueller A., Kamp D. W., Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis Chemico-Biological Interactions 2010 188 2 309 318
42. Fubini B., Hubbard A., Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis Free Radical Biology and Medicine 2003 34 12 1507 1516 (Pubitemid 36638711)
43. Upadhyay D., Kamp D. W., Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis Experimental Biology and Medicine 2003 228 6 650 659 (Pubitemid 37163254)
44. Shukla A., Gulumian M., Hei T. K., Kamp D., Rahman Q., Mossman B. T., Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases Free Radical Biology and Medicine 2003 34 9 1117 1129 (Pubitemid 36423362)
45. Miura Y., Nishimura Y., Katsuyama H., Maeda M., Hayashi H., Dong M., Hyodoh F., Tomita M., Matsuo Y., Uesaka A., Kuribayashi K., Nakano T., Kishimoto T., Otsuki T., Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells Apoptosis 2006 11 10 1825 1835 (Pubitemid 44371055)
46. Miura Y., Nishimura Y., Maeda M., Murakami S., Hayashi H., Fukuoka K., Kishimoto T., Nakano T., Otsuki T., Immunological alterations found in mesothelioma patients and supporting experimental evidence Environmental Health and Preventive Medicine 2008 13 2 55 59
47. Murakami S., Nishimura Y., Maeda M., Kumagai N., Hayashi H., Chen Y., Kusaka M., Kishimoto T., Otsuki T., Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases Environmental Health and Preventive Medicine 2009 14 4 216 222
48. Maeda M., Nishimura Y., Kumagai N., Hayashi H., Hatayama T., Katoh M., Miyahara N., Yamamoto S., Hirastuka J., Otsuki T., Dysregulation of the immune system caused by silica and asbestos Journal of Immunotoxicology 2010 7 4 268 278
49. Wenzel J., Tting T., An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis" Journal of Investigative Dermatology 2008 128 10 2392 2402
50. Strieter R. M., Burdick M. D., Mestas J., Gomperts B., Keane M. P., Belperio J. A., Cancer CXC chemokine networks and tumour angiogenesis European Journal of Cancer 2006 42 6 768 778
51. Maeda M., Nishimura Y., Hayashi H., Reduction of CXCR3 in an in vitro model of continuous asbestos exposure on a human T-cell line, MT-2. American Journal of Respiratory Cell and Molecular Biology. In press
52. Maeda M., Nishimura Y., Hayashi H., Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. American Journal of Respiratory Cell and Molecular Biology. In press
53. Nishimura Y., Miura Y., Maeda M., Kumagai N., Murakami S., Hayashi H., Fukuoka K., Nakano T., Otsuki T., Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers International Journal of Immunopathology and Pharmacology 2009 22 3 579 590
54. Nishimura Y., Maeda M., Kumagai N., Hayashi H., Miura Y., Otsuki T., Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos International Journal of Immunopathology and Pharmacology 2009 22 4 879 888
55. Nishimura Y., Kumagai N., Maeda M., Hayashi H., Fukuoka K., Nakano T., Miura Y., Hiratsuka J., Otsuki T., Suppressive effect of asbestos on cytotoxicity of human NK cells International Journal of Immunopathology and Pharmacology 2011 24 supplement 1 5S 10S